FDA approves FluLaval Quadrivalent influenza vaccine for persons three years and older
Pharmaceutical, biologics and vaccine company, GlaxoSmithKline (GSK), announced Friday that the Food and Drug Administration (FDA) has approved FluLaval Quadrivalent influenza vaccine for the active immunization More...
GlaxoSmithKline’s Fluarix Quadrivalent receives FDA approval
CDC/ Debora Cartagena The first intramuscular vaccine to cover against four influenza strains has just received US Food and Drug Administration (FDA) approval, according to a GlaxoSmithKline (GSK) press release More...
